Vertex Reports First-Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500, Nasdaq futures rise on tech boost
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Oil rises on Iran war stalemate; near-term potential for further gains seen limited
- L3Harris CEO steps down amid conduct review, shares drop
Vertex Pharma (VRTX) Tops Q1 EPS by 16c, Revenues Beat; Affirms FY19 Revenue Guidance Below Consensus
April 30, 2019 4:04 PM EDTVertex Pharma (NASDAQ: VRTX) reported Q1 EPS of $1.14, $0.16 better than the analyst estimate of $0.98. Revenue for the quarter came in at $857 million versus the consensus estimate of $850.93 million.
First-quarter 2019 product revenues of $857 million, a 34% increase compared to $638 million in 2018-First-quarter 2019 GAAP operating income increased 115% to $277 million;... More